|
NUAK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.54419810272088E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.66018368128607E-12 |
| Normal-vs-Stage2 |
1.34350308655939E-11 |
| Normal-vs-Stage3 |
1.19680043653148E-10 |
| Normal-vs-Stage4 |
4.01999544763498E-11 |
| Stage1-vs-Stage2 |
4.877200E-01 |
| Stage1-vs-Stage3 |
1.385660E-02 |
| Stage1-vs-Stage4 |
5.543000E-01 |
| Stage2-vs-Stage3 |
1.581350E-01 |
| Stage2-vs-Stage4 |
9.279400E-01 |
| Stage3-vs-Stage4 |
2.964200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.40409905924344E-11 |
| Normal-vs-AfricanAmerican |
2.41280329049687E-11 |
| Normal-vs-Asian |
5.792200E-04 |
| Caucasian-vs-AfricanAmerican |
2.227600E-01 |
| Caucasian-vs-Asian |
1.669970E-01 |
| AfricanAmerican-vs-Asian |
3.369400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.9914521101141E-12 |
| Normal-vs-Female |
4.67980099116971E-11 |
| Male-vs-Female |
8.662800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.49970044663428E-11 |
| Normal-vs-Extreme_Weight |
6.48248121848383E-12 |
| Normal-vs-Obese |
1.32459598845003E-11 |
| Normal-vs-Extreme_Obese |
4.23489999999971E-05 |
| Normal_Weight-vs-Extreme_Weight |
6.569600E-02 |
| Normal_Weight-vs-Obese |
4.656000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.051600E-01 |
| Extreme_Weight-vs-Obese |
2.470800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.331000E-01 |
| Obese-vs-Extreme_Obese |
5.750600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.04249999999251E-06 |
| Normal-vs-Age(41-60Yrs) |
1.202504762432E-11 |
| Normal-vs-Age(61-80Yrs) |
1.41290312782871E-11 |
| Normal-vs-Age(81-100Yrs) |
1.97808436297464E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.076390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.435630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.527900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.436800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.028000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.866370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.43844960784645E-12 |
| Normal-VS-Type2 PRCC |
6.53590515042879E-11 |
| Normal-VS-KIRP CIMP |
2.248200E-04 |
| Normal-VS-Unclassified PRCC |
1.18239862345604E-11 |
| Type1 PRCC-VS-Type2 PRCC |
2.975800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.246100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.191870E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.594970E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.617600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.540000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.99214036564899E-12 |
| Normal-vs-N1 |
2.34109998054066E-09 |
| Normal-vs-N2 |
7.80399966870959E-10 |
| N0-vs-N1 |
1.293620E-02 |
| N0-vs-N2 |
1.234370E-01 |
| N1-vs-N2 |
4.437800E-01 |
|
|
